Projects per year
Personal profile
Biography
Ian Glaspole performs translational and clinical research in interstitial lung diseases, such as idiopathic pulmonary fibrosis. He is the director of the Interstitial Lung Disease Clinic at the Alfred Hospital, Melbourne. He is an adjunct clinical associate professor of medicine at Monash University’s Central Clinical School Campus.
A/Prof Glaspole has maintained a strong research focus since completing his PhD, within which he studied the human cellular immune response to nut allergens. Since then, his research has focused on interstitial lung disease, and has included numerous clinical trials exploring treatments for idiopathic pulmonary fibrosis, along with other clinical and laboratory based research, principally focused on improving the symptoms and quality of life of sufferers of these rare lung diseases.
His research is funded by the NHMRC, and philanthropic and industry sources. He serves on advisory boards and steering committees for clinical trials in idiopathic pulmonary fibrosis (IPF) and other forms of lung fibrosis. He is the co-chair of the Australian IPF Registry, and a steering committee member of the Centre for Research Excellence in Pulmonary Fibrosis.
A/Prof Glaspole is a member of the Thoracic Society of Australia & New Zealand, the Australian Society of Clinical Immunology and Allergy, and the Australian Sleep Association.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Interstitial lung disease
-
Design and Implementation of a Revised Telemedicine Model for ILD
Deshpande, S. U., Glaspole, I., Holland, A. & Khor, Y.
3/05/22 → 2/05/23
Project: Research
-
A randomized, double-blind, dose-ranging, placebo-controlled Phase 2a evaluation of the safety, tolerability, and pharmacokinetics of PLN-74809 in participants with idiopathic pulmonary fibrosis (IPF) (INTEGRIS-IPF).
Glaspole, I., Corte, T. J. & Symons, K. M.
23/03/22 → 31/12/24
Project: Research
-
A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
Glaspole, I. & Symons, K. M.
30/08/21 → 31/12/24
Project: Research
-
A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
Glaspole, I. & Symons, K. M.
1/07/21 → 31/12/24
Project: Research
-
Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis
Glaspole, I. & Symons, K. M.
18/06/21 → 31/12/24
Project: Research
-
Self-management for pulmonary fibrosis: Insights from people living with the disease and healthcare professionals
Lee, J. Y. T., Tikellis, G., Glaspole, I., Khor, Y. H., Symons, K. & Holland, A. E., Apr 2022, In: Patient Education and Counseling. 105, 4, p. 956-964 9 p.Research output: Contribution to journal › Article › Research › peer-review
-
The Perceptions of Telehealth Physiotherapy for People with Bronchiectasis during a Global Pandemic-A Qualitative Study
Lee, A. L., Tilley, L., Baenziger, S., Hoy, R. & Glaspole, I., 1 Mar 2022, In: Journal of Clinical Medicine. 11, 5, 11 p., 1315.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*
Jee, A. S., Sheehy, R., Hopkins, P., Corte, T. J., Grainge, C., Troy, L. K., Symons, K., Spencer, L. M., Reynolds, P. N., Chapman, S., de Boer, S., Reddy, T., Holland, A. E., Chambers, D. C., Glaspole, I. N., Jo, H. E., Bleasel, J. F., Wrobel, J. P., Dowman, L., Parker, M. J. S. & 4 others, , Jan 2021, In: Respirology. 26, 1, p. 23-51 29 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access7 Citations (Scopus) -
Moderate resting hypoxaemia in fibrotic interstitial lung disease
Khor, Y. H., Harrison, A., Robinson, J., Goh, N. S. L., Glaspole, I. & McDonald, C. F., 2021, In: European Respiratory Journal. 57, 1, 4 p., 2001563.Research output: Contribution to journal › Letter › Other › peer-review
Open Access1 Citation (Scopus) -
Physical activity decline is disproportionate to decline in pulmonary physiology in IPF
Prasad, J. D., Paul, E., Holland, A. E., Glaspole, I. N. & Westall, G. P., Dec 2021, In: Respirology. 26, 12, p. 1152-1159 8 p.Research output: Contribution to journal › Article › Research › peer-review